The 2018 BIO CEO & Investor Conference took place in New York City on February 12-13 in New York City. This Conference remains one of the largest investor conferences focused on established and emerging publicly traded and select private biotech companies.
CheckRare had the opportunity to sit down with Dr. John Maraganore who has served as the CEO and a Director of Alnylam since 2002 and is the Chair of the Biotechnology Innovation Organization (BIO) for the 2017-2018 term.
BIO is the world’s largest trade association representing biotechnology companies, academic institutions, state biotechnology centers and related organizations across the United States and in more than 30 other nations. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology products.
The conference featured presentations by over 175 leading biotechnology and pharmaceutical companies, as well as a number of nonprofit and venture philanthropy organizations. Here are just a few of the company’s who we had the opportunity to meet with.
Presenting companies are hand-selected for the event, and consist of a selection of mid- to large-cap established public companies from around the globe, who typically have a clinical stage program centered around therapeutics, molecular diagnostics, or a platform technology, as well as an upcoming clinical, regulatory, or corporate catalyst. Here’s a complete list of company’s at this year’s Conference.
| Abide Therapeutics |
| Actinium Pharmaceuticals, Inc. (NYSE American:ATNM) |
| Adocia (Euronext Paris:ADOC) |
| Akebia Therapeutics, Inc. (NASDAQ:AKBA) |
| Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) |
| Amygdala Neurosciences, Inc. |
| Anavex Life Sciences Corp. (NASDAQ:AVXL) |
| Aralez Pharmaceuticals (NASDAQ:ARLZ) |
| Aravive Biologics |
| Armis Biopharma, Inc. |
| ASDERA LLC |
| Association for Women in Science (AWIS) |
| Aucta Pharmaceuticals Inc. |
| Avidity Biosciences LLC |
| Axsome Therapeutics (NASDAQ:AXSM) |
| AzurRx BioPharma, Inc. (NASDAQ:AZRX) |
| Bellerophon Therapeutics (NASDAQ:BLPH) |
| Berlin Cures |
| Bioasis Technologies Inc. (TSX.V / OTCQB:BTI / BIOAF) |
| BioLife Solutions, Inc. (NASDAQ:BLFS) |
| BioLineRx Ltd. (NASDAQ:BLRX) |
| Bio-Path Holdings, Inc. (NASDAQ:BPTH) |
| BioTime (NYSE:BTX) |
| Boston Pharmaceuticals |
| Brainstorm Cell Therapeutics Inc (NASDAQ:BCLI) |
| BriaCell Therapeutics Corp. (TSX:BCT.V) |
| Brillance |
| Caladrius Biosciences, Inc. (NASDAQ:CLBS) |
| Can-Fite BioPharma Ltd. (NYSE:CANF) |
| Cardiol Therapeutics Inc |
| CASI Pharmaceuticals, Inc. (NASDAQ:CASI) |
| Catalyst Biosciences (NASDAQ:CBIO) |
| Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) |
| Cellectar Biosciences (NASDAQ:CLRB) |
| CEL-SCI Corporation (NYSE American:CVM) |
| Cerecor Inc (NASDAQ:CERC) |
| Cesca Therapeutics, Inc. (NASDAQ:KOOL) |
| Checkpoint Therapeutics, Inc. (NASDAQ:CKPT) |
| Chembio Diagnostics, Inc. (NASDAQ:CEMI) |
| CHF Solutions, Inc. (NASDAQ:CHFS) |
| Citius Pharmaceuticals, Inc. (NASDAQ:CTXR) |
| Conatus Pharmaceuticals Inc. (NASDAQ GM:CNAT) |
| ContraVir Pharmaceuticals (NASDAQ:CTRV) |
| Corium International, Inc. (NASDAQ:CORI) |
| Cue Biopharma (NASDAQ:CUE) |
| Curetis N.V. (Euronext Amsterdam & Euronext Brussels:CURE) |
| Cyclacel Pharmaceuticals, Inc. (NASDAQ:CYCC) |
| CytoDyn, Inc. (OTC Markets:CYDY) |
| CytoSorbents Corporation (NASDAQ:CTSO) |
| CytRx Corporation (NASDAQ:CYTR) |
| Daré Bioscience, Inc. (NASDAQ:DARE) |
| Denovo Biopharma LLC |
| Diffusion Pharmaceuticals Inc. (NASDAQ:DFFN) |
| Dyadic International, Inc. (OTCQX:DYAI) |
| Editas Medicine, Inc. (NASDAQ:EDIT) |
| Eiger BioPharmaceuticals, Inc (NASDAQ:EIGR) |
| Eleven Biotherapeutics, Inc. (NASDAQ:EBIO) |
| Enterome Biosciences |
| Erytech Pharma (NASDAQ:ERYP) |
| Espero BioPharma, Inc. |
| Exicure Inc. (OTCQB:XCUR) |
| Eyegate Pharmaceuticals, Inc. (NASDAQ:EYEG) |
| Femeda Ltd |
| Fibrocell Science, Inc. (NASDAQ:FCSC) |
| Flex Pharma (NASDAQ:FLKS) |
| Forty Seven Inc. |
| Galectin Therapeutics, Inc. (NASDAQ:GALT) |
| gel-e, Inc. |
| Genervon Biopharmaceuticals, LLC |
| Gila Therapeutics, Inc. |
| Gradalis, Inc. |
| Graybug Vision, Inc |
| Gritstone Oncology, Inc. |
| H3 Biomedicine |
| Heat Biologics (NASDAQ:HTBX) |
| Hemispherx Biopharma, Inc. (NYSE:HEB) |
| Humanetics Corporation |
| Humanigen, Inc. (OTCQB:HGEN) |
| Immune Pharmaceuticals Inc. (NASDAQ:IMNP) |
| Immuneering Corporation |
| Immunic AG |
| Immunicum AB (NASDAQ Stockholm:IMMU.ST) |
| Immunomic Therapeutics, Inc. |
| Immunovaccine Inc (TSX, OTCQX:IMV, IMMVF) |
| ImmusanT, Inc. |
| Infinity Pharmaceuticals, Inc. (NASDAQ:INFI) |
| Innovate Biopharmaceuticals, Inc. (Nasdaq:INNT) |
| Inovio Pharmaceuticals (NASDAQ:INO) |
| Intensity Therapeutics, Inc. |
| InteRNA Technologies B.V. |
| Interpace Diagnostics (NASDAQ:IDXG) |
| Invitae Corporation (NYSE:NVTA) |
| Lakewood-Amedex, Inc. |
| Landos Biopharma |
| Lantern Pharma Inc |
| Leading BioSciences |
| Leap Therapeutics Inc. (NASDAQ:LPTX) |
| Lung Therapeutics, Inc. |
| MabVax Therapeutics Holdings, Inc. (NASDAQ:MBVX) |
| MangoGen Pharma |
| MaxCyte, Inc. (AIM, LSE:MXCT; MXCR) |
| Mikro Biyosistemler Elektronik Sanayi ve Ticaret AŞ |
| Moberg Pharma AB (Nasdaq Stockholm:MOB.ST) |
| Morphic Therapeutic Inc. |
| Muscular Dystrophy Association (MDA) |
| NanOlogy LLC |
| Nemus Bioscience, Inc. (OTCQB:NMUS) |
| Neuraltus Pharmaceuticals, Inc. |
| NeuroActiva, Inc. |
| NeuroRx, Inc. |
| Neurotrope (Nasdaq:NTRP) |
| NewLink Genetics (NASDAQ:NLNK) |
| NEWRON PHARMACEUTICALS SPA (SIX:NWRN) |
| Novoclem Therapeutics |
| Ocugen, Inc. |
| OncoCyte Corporation (NYSE American:OCX) |
| OncoQuest, Inc. |
| Opsona Therapeutics Limited |
| Oramed pharmaceuticals (NASDAQ:ORMP) |
| Orig3n, Inc. |
| OrphoMed, Inc. |
| ORYZON GENOMICS SA (BOLSA :ORY) |
| PAION AG (Xetra, FSE:PA8) |
| Palatin Technologies, Inc. (NYSE:MKT:PTN) |
| Palladio Biosciences, Inc. |
| Pear Therapeutics, Inc. |
| Precision NanoSystems |
| Probiodrug AG (Euronext Amsterdam:PBD) |
| Progenics Pharmaceuticals, Inc. (NASDAQ:PGNX) |
| pSivida Corp (NASDAQ:PSDV) |
| Race Oncology Ltd (ASX:RAC) |
| Rain Therapeutics Inc. |
| Recombinetics. Inc. |
| RedHill Biopharma Ltd. (NASDAQ, TASE:RDHL) |
| Regenerative Medical Services Ltd. |
| Resverlogix Corp. (TSX:RVX) |
| RXi Pharmaceuticals Corporation (NASDAQ:RXII) |
| Saghmos Therapeutics, Inc. |
| Sanuwave Health, Inc. (OTCQB:SNWV) |
| Savara, Inc. (NASDAQ:SVRA) |
| Scientist.com |
| SELLAS Life Sciences Group, Inc. (NASDAQ:SLS) |
| Serina Therapeutics, Inc. |
| Sierra Oncology (NASDAQ:SRRA) |
| Sigilon Therapeutics Inc |
| Spyryx Biosciences, Inc. |
| SQZ Biotechnologies |
| Summit Therapeutics plc (NASDAQ:SMMT) |
| TAHO Pharmaceuticals Ltd. (TPEX:tw.6467) |
| TapImmune Inc (NASDAQ:TPIV) |
| Tarveda Therapeutics, Inc. |
| TAXIS Pharmaceuticals Inc. |
| Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) |
| TraceLink |
| Vericel Corporation (NASDAQ:VCEL) |
| Vidac Pharma |
| Viking Therapeutics, Inc. (NASDAQ:VKTX) |
| WuXi NextCODE |